Video

Exploring Value Based Contracting

Norris Turner, PharmD, PhD, vice president of Strategic Alliances and Measures at PQA, discusses value-based contracts and the demand for medication measurements in Medicaid during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Norris Turner, PharmD, PhD, vice president of Strategic Alliances and Measures at Pharmacy Quality Alliance (PQA) discusses value-based contracts and the demand for medication measurements in Medicaid during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Norris Turner, PharmD, PhD: So, value-based contracting in Medicaid is certainly an area of exploration. I don’t know that anyone knows whether if that’s going to be a stable solution that’s solving the intended problem. But certainly, at the heart of any value-based agreement, often it is medication related. So, you need some sort of a measurement to assess whether or not you’re achieving the aims of a contract. And, no better way to try to do that than a standardized measure where there has been sufficient testing and validation of that measure. So, there are certainly opportunities to enter into that contract if in fact value-based contracting in Medicaid ends up being an important solution going forward.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com